Tiwari, B. 2025. FDA Approved Durvalumab for Limited-Stage Small Cell Lung Cancer. Nepalese Journal of Cancer. 9, 1 (Apr. 2025), 9–14. DOI:https://doi.org/10.3126/njc.v9i1.77006.